[
  {
    "ts": "2026-02-26T02:50:09+00:00",
    "headline": "RBC Capital Initiates Pfizer (PFE) with $25 Target, Warns of Structural Revenue Headwinds",
    "summary": "Pfizer Inc. (NYSE:PFE) is included among the 14 Best Affordable Dividend Stocks to Buy According to Analysts. On February 25, RBC Capital initiated coverage of Pfizer Inc. (NYSE:PFE) with an Underperform rating and a $25 price target. The firm said its outlook reflects an “insurmountable” $15B-$20B revenue decline expected through 2030, with limited visibility into […]",
    "url": "https://finance.yahoo.com/news/rbc-capital-initiates-pfizer-pfe-025009670.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ef4c3040-d87d-3ccf-9c6c-db8a9f6f2be0",
      "content": {
        "id": "ef4c3040-d87d-3ccf-9c6c-db8a9f6f2be0",
        "contentType": "STORY",
        "title": "RBC Capital Initiates Pfizer (PFE) with $25 Target, Warns of Structural Revenue Headwinds",
        "description": "",
        "summary": "Pfizer Inc. (NYSE:PFE) is included among the 14 Best Affordable Dividend Stocks to Buy According to Analysts. On February 25, RBC Capital initiated coverage of Pfizer Inc. (NYSE:PFE) with an Underperform rating and a $25 price target. The firm said its outlook reflects an “insurmountable” $15B-$20B revenue decline expected through 2030, with limited visibility into […]",
        "pubDate": "2026-02-26T02:50:09Z",
        "displayTime": "2026-02-26T02:50:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/30173640c9b0cffb6b7013930030fa3e",
          "originalWidth": 1920,
          "originalHeight": 1275,
          "caption": "RBC Capital Initiates Pfizer (PFE) with $25 Target, Warns of Structural Revenue Headwinds",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TkRKqkPAOo0eEJXaJY9Y2A--~B/aD0xMjc1O3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/30173640c9b0cffb6b7013930030fa3e.cf.webp",
              "width": 1920,
              "height": 1275,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pTG9ApYeTSmSfYp_rFmJ.g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/30173640c9b0cffb6b7013930030fa3e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rbc-capital-initiates-pfizer-pfe-025009670.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rbc-capital-initiates-pfizer-pfe-025009670.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-26T13:00:00+00:00",
    "headline": "Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights",
    "summary": "Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and year ended December 31, 2025.",
    "url": "https://finance.yahoo.com/news/novavax-reports-fourth-quarter-full-130000702.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "adb71593-4a36-3dcc-ae54-ad496b7b3877",
      "content": {
        "id": "adb71593-4a36-3dcc-ae54-ad496b7b3877",
        "contentType": "STORY",
        "title": "Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights",
        "description": "",
        "summary": "Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and year ended December 31, 2025.",
        "pubDate": "2026-02-26T13:00:00Z",
        "displayTime": "2026-02-26T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/1c42c28c8563f8f4990614a5b57621a0",
          "originalWidth": 400,
          "originalHeight": 176,
          "caption": "Novavax Logo (PRNewsfoto/Novavax)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lGAm3yWPXe2PzUrTUxfKZw--~B/aD0xNzY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/1c42c28c8563f8f4990614a5b57621a0.cf.webp",
              "width": 400,
              "height": 176,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1beS42kfkrJ3Bw2q.H.8UA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/1c42c28c8563f8f4990614a5b57621a0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novavax-reports-fourth-quarter-full-130000702.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novavax-reports-fourth-quarter-full-130000702.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVAX"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "TAK"
            },
            {
              "symbol": "302440.KS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-26T13:46:00+00:00",
    "headline": "Novavax shares subdued despite earnings, revenue beat",
    "summary": "Investing.com -- Novavax Inc. (NASDAQ:NVAX) reported fourth quarter results that exceeded analyst expectations. Shares initially fell premarket, but now trade around 0.7% higher.",
    "url": "https://finance.yahoo.com/news/novavax-shares-subdued-despite-earnings-134600080.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "6b2fd386-a5dd-325c-a1e7-acbabbfeaa4c",
      "content": {
        "id": "6b2fd386-a5dd-325c-a1e7-acbabbfeaa4c",
        "contentType": "STORY",
        "title": "Novavax shares subdued despite earnings, revenue beat",
        "description": "",
        "summary": "Investing.com -- Novavax Inc. (NASDAQ:NVAX) reported fourth quarter results that exceeded analyst expectations. Shares initially fell premarket, but now trade around 0.7% higher.",
        "pubDate": "2026-02-26T13:46:00Z",
        "displayTime": "2026-02-26T13:46:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novavax-shares-subdued-despite-earnings-134600080.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novavax-shares-subdued-despite-earnings-134600080.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVAX"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-26T09:32:38+00:00",
    "headline": "Cardiff Oncology Spotlights Onvansertib Data at Oppenheimer: 72% ORR in RAS-Mutant mCRC",
    "summary": "Cardiff Oncology (NASDAQ:CRDF) used an appearance at Oppenheimer’s 36th Annual Healthcare Conference to highlight updated clinical results and its development plans for onvansertib, an oral, highly selective polo-like kinase 1 (PLK1) inhibitor being studied in RAS-mutated metastatic colorectal cance",
    "url": "https://www.marketbeat.com/instant-alerts/cardiff-oncology-spotlights-onvansertib-data-at-oppenheimer-72-orr-in-ras-mutant-mcrc-2026-02-26/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "21d89801-4c84-3a26-9d42-5f5144912ec2",
      "content": {
        "id": "21d89801-4c84-3a26-9d42-5f5144912ec2",
        "contentType": "STORY",
        "title": "Cardiff Oncology Spotlights Onvansertib Data at Oppenheimer: 72% ORR in RAS-Mutant mCRC",
        "description": "",
        "summary": "Cardiff Oncology (NASDAQ:CRDF) used an appearance at Oppenheimer’s 36th Annual Healthcare Conference to highlight updated clinical results and its development plans for onvansertib, an oral, highly selective polo-like kinase 1 (PLK1) inhibitor being studied in RAS-mutated metastatic colorectal cance",
        "pubDate": "2026-02-26T09:32:38Z",
        "displayTime": "2026-02-26T09:32:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/865d06ec0380b4f1f2c18cf49108070d",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Cardiff Oncology logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BDeyTkxj2c_tdr5S4VlIMg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/865d06ec0380b4f1f2c18cf49108070d.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ACmtmoZKm2TFza85nSUO4A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/865d06ec0380b4f1f2c18cf49108070d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/cardiff-oncology-spotlights-onvansertib-data-at-oppenheimer-72-orr-in-ras-mutant-mcrc-2026-02-26/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cardiff-oncology-spotlights-onvansertib-data-093238040.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRDF"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-26T21:11:44+00:00",
    "headline": "Novavax Inc (NVAX) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ...",
    "summary": "Novavax Inc (NVAX) reports a 65% revenue increase and secures major partnerships, despite facing regulatory uncertainties and strategic challenges.",
    "url": "https://finance.yahoo.com/news/novavax-inc-nvax-q4-2025-211144949.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "073974c8-5001-3679-86b9-1874c97d74e8",
      "content": {
        "id": "073974c8-5001-3679-86b9-1874c97d74e8",
        "contentType": "STORY",
        "title": "Novavax Inc (NVAX) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ...",
        "description": "",
        "summary": "Novavax Inc (NVAX) reports a 65% revenue increase and secures major partnerships, despite facing regulatory uncertainties and strategic challenges.",
        "pubDate": "2026-02-26T21:11:44Z",
        "displayTime": "2026-02-26T21:11:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novavax-inc-nvax-q4-2025-211144949.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novavax-inc-nvax-q4-2025-211144949.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVAX"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "SNY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-26T13:30:00+00:00",
    "headline": "Novavax, Inc. Q4 2025 Earnings Call Summary",
    "summary": "Moby summary of Novavax, Inc.'s Q4 2025 earnings call",
    "url": "https://app.moby.co/home/research/tools/earningsCalendar/earnings-novavax-inc-q4-2025-earnings-call-summary?utm_source=yahoo_finance&utm_medium=rss",
    "source": "Moby",
    "provider": "yfinance",
    "raw": {
      "id": "24aad202-20b8-30fe-8c5e-536e9af5a545",
      "content": {
        "id": "24aad202-20b8-30fe-8c5e-536e9af5a545",
        "contentType": "STORY",
        "title": "Novavax, Inc. Q4 2025 Earnings Call Summary",
        "description": "",
        "summary": "Moby summary of Novavax, Inc.'s Q4 2025 earnings call",
        "pubDate": "2026-02-26T13:30:00Z",
        "displayTime": "2026-02-26T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/moby_896/5deda4cfc1e7b3de864f32482eb15c33",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Novavax, Inc. Q4 2025 Earnings Call Summary",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d0WRQi8M3LQtlQgafNekyQ--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/moby_896/5deda4cfc1e7b3de864f32482eb15c33.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TIAzJjljDWvkdkCTPAMZmw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moby_896/5deda4cfc1e7b3de864f32482eb15c33.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Moby",
          "url": "https://moby.co/"
        },
        "canonicalUrl": {
          "url": "https://app.moby.co/home/research/tools/earningsCalendar/earnings-novavax-inc-q4-2025-earnings-call-summary?utm_source=yahoo_finance&utm_medium=rss",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novavax-inc-q4-2025-earnings-133000568.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVAX"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "TAK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-26T21:11:00+00:00",
    "headline": "Top Research Reports for Meta, Netflix & Pfizer",
    "summary": "Meta Platforms, Netflix and Pfizer lead fresh research as AI bets, bold 2030 goals and patent cliffs shape their outlooks.",
    "url": "https://finance.yahoo.com/news/top-research-reports-meta-netflix-211100549.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9a20d199-c05a-32cc-8c9e-d68030bfdd6d",
      "content": {
        "id": "9a20d199-c05a-32cc-8c9e-d68030bfdd6d",
        "contentType": "STORY",
        "title": "Top Research Reports for Meta, Netflix & Pfizer",
        "description": "",
        "summary": "Meta Platforms, Netflix and Pfizer lead fresh research as AI bets, bold 2030 goals and patent cliffs shape their outlooks.",
        "pubDate": "2026-02-26T21:11:00Z",
        "displayTime": "2026-02-26T21:11:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/2f626712e0f8bd8c8c921742aa267402",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Qk7_juHNb8D8VM7idpSOgw--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2f626712e0f8bd8c8c921742aa267402.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iLq.d0N1zFeXqJiiBn0Gxg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2f626712e0f8bd8c8c921742aa267402.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-research-reports-meta-netflix-211100549.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-research-reports-meta-netflix-211100549.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NFLX"
            },
            {
              "symbol": "EPD"
            },
            {
              "symbol": "ITUB"
            },
            {
              "symbol": "CVNA"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "SIF"
            },
            {
              "symbol": "ATGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]